Fragmin (Pfizer Laboratories Div Pfizer Inc)
Welcome to the PulseAid listing for the Fragmin drug offered from Pfizer Laboratories Div Pfizer Inc. This Anti-coagulant [EPC],Heparin, Low-Molecular-Weight [Chemical/Ingredient],Low Molecular Weight Heparin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc |
NON-PROPRIETARY NAME: | Dalteparin Sodium |
SUBSTANCE NAME: | DALTEPARIN SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anti-coagulant [EPC],Heparin, Low-Molecular-Weight [Chemical/Ingredient],Low Molecular Weight Heparin [EPC] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-04-01 |
END MARKETING DATE: | 0000-00-00 |
Fragmin HUMAN PRESCRIPTION DRUG Details:
Item Description | Fragmin from Pfizer Laboratories Div Pfizer Inc |
LABELER NAME: | Pfizer Laboratories Div Pfizer Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2500([iU]/.2mL) |
START MARKETING DATE: | 2015-04-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0069-0195_35ed2da4-58fb-44ae-ae4d-13769110c855 |
PRODUCT NDC: | 0069-0195 |
APPLICATION NUMBER: | NDA020287 |
Other DALTEPARIN SODIUM Pharmaceutical Manufacturers / Labelers: